Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about the effects of abdominal compression and the
medication midodrine, two interventions used for the treatment of orthostatic hypotension
(low blood pressure on standing), on hemodynamic markers of cardiovascular risk. The study
will be conducted at the Vanderbilt University Medical Center and consists of a screening and
2 testing days, one with abdominal compression and one with midodrine. The total length of
the study will be about 5 days.